Innate lymphoid cells and tissue adaptation to changing metabolic needs

This project aims to elucidate the role of ILC3 and the IL-22:IL-22BP module in intestinal adaptation to metabolic changes, with implications for understanding and treating metabolic diseases.

Subsidie
€ 2.379.266
2022

Projectdetails

Introduction

Border surfaces of vertebrate organisms are in constant exchange with their habitat. Host cell networks consisting of epithelial cells, stroma, and tissue-resident immune cells continuously integrate signals from the environment, a process by which an organism becomes better suited to its habitat (i.e., adaptation). Our understanding of the molecular underpinnings of such homeostatic processes is in its infancy, yet they are decisive for proper organ function.

Background

Recently, we and others have identified homeostatic circuitry involving tissue-resident immune cells in the small intestine facilitating adaptation to changes in nutrient cargo. The goal of my laboratory is to capture these molecular networks and to investigate how their failure predisposes to diseases.

Research Objectives

This proposal aims to systematically define the role of mucosa-associated group 3 innate lymphoid cells (ILC3) and of the IL-22:IL-22BP module in tissue adaptation to changes in metabolic need via their interaction with intestinal stem cells, stromal cells, and enteroendocrine cells (EEC).

Methodology

Answering these questions demands both focused and global experimental approaches as well as the use of new genetic models for targeting of ILC3 and for recording epithelial cell differentiation.

Specific Aims

Based on these considerations and on strong preliminary data, we have devised 3 Specific Aims that will allow an unprecedented analysis of ILC3-controlled tissue adaptation:

  1. To understand intestinal ILC3-epithelial cell units regulating nutrient handling and systemic metabolism.
  2. To test the role of ILC3 in intestinal adaptation to increased metabolic demand during pregnancy.
  3. To characterize a new immune-epithelial module consisting of EEC and IL-22-producing ILC3.

Implications

We and others have demonstrated that ILC3 effector programs are highly conserved and are operative in humans. Thus, the anticipated results will carry tremendous implications for the prevention and therapy of metabolic diseases.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.379.266
Totale projectbegroting€ 2.379.266

Tijdlijn

Startdatum1-11-2022
Einddatum31-10-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

T cell regulation by fed state bacterial metabolites

This project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health.

€ 1.499.548
ERC Advanced...

Architecture of Peripheral Neuroimmune Circuits and Synapses

This project aims to explore neuro-ILC2 interactions in vivo using innovative labelling tools to enhance understanding of neuroimmune dynamics and their implications for tissue health and disease.

€ 3.500.000
ERC Starting...

Deconstructing Intestinal Immune Tolerance

This project aims to dissect the intestinal immune regulatory network using chemical genetic protein degradation to understand the role of Foxp3+ Treg cells in maintaining immune tolerance.

€ 1.500.000
ERC Consolid...

Tracking adaptation of naïve T cells to distinct organs to decode organ-specific immune diseases

This project investigates how organ-adapted naïve CD4+ T cells contribute to organ-specific immune-mediated inflammatory diseases triggered by environmental factors, aiming to enhance precision medicine approaches.

€ 1.999.000
ERC Starting...

Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and Cancer

This project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets.

€ 2.025.000